cancer

Pricey Precision Medicine Often Financially Toxic For Cancer Patients

The high cost of cutting-edge tests and treatments is threatening to keep precision medicine — one of the most celebrated areas in cancer research — out of reach for many patients.

When Kristen Kilmer was diagnosed with incurable breast cancer at age 38, her first thought was of her 8-year-old daughter. Kilmer had lost her own mother as a teenager and was determined to get more time with her only child.

Pages

Subscribe to cancer